Versant Capital Management »

Eyepoint Pharmaceuticals shares owned by Versant Capital Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $23k 1.3k 18.27
2025-09-30 $18k 1.3k 14.24
2025-06-30 $12k 1.3k 9.41
2025-03-31 $4.0k 741 5.42
2024-12-31 $3.7k 492 7.45

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vaneck Gold Miners Etf Etf (GDX)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Federated Investors
Adage Capital Partners GP
Franklin Resources
Vanguard Group
Paradigm Biocapital Advisors
TCG Crossover Management
OrbiMed Advisors
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals